4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Fei, C; Guo, J; Li, X; Zhao, S; Zhao, Y; Zheng, Q | 1 |
1 other study(ies) available for 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation.
Topics: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase 1; Mesenchymal Stem Cells; Middle Aged; Myelodysplastic Syndromes; Oligopeptides; RNA Interference; Young Adult | 2017 |